Author:
Angelousi Anna,Kaltsas Gregory,Koumarianou Anna,Weickert Martin O.,Grossman Ashley
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference127 articles.
1. Tsikitis VL, Wertheim BC, Guerrero MA. Trends of incidence and survival of gastrointestinal neuroendocrine tumours in the United States: a seer analysis. J Cancer. 2012;3:292–302.
2. Yao JC, Hassan M, Phan A, et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumours in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–72.
3. Huguet I, Grossman AB, O’Toole D. The epidemiology of NETs - is their incidence really increasing? Neuroendocrinology. 2015;104:105–11.
4. Strosberg JR, Coppola D, Klimstra DS, et al. The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas. North American neuroendocrine tumour society (NANETS). Pancreas. 2010;39:799–800.
5. SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2010 Sub (1973–2008) Katrina/Rita Population Adjustment - Linked To County Attributes - Total US, 1969–2009 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2011, based on the November 2010 submission.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献